- Seattle Genetics seeks expanded Adcetris use in HL, sALCL
- $25m upfront for Seattle Genetics as Abbott expands ADC alliance
- Takeda files for Japanese approval of brentuximab
- AACR PREVIEW: Early look at new cancer therapies
ONLY 0 DAY LEFT
|Stay close to your market. Renew online now to ensure uninterrupted access to:|
|SCRIP Intelligence's news and expert commentary|
|Market Data and Company Analysis (SCRIP 100, SCRIP Asia 100)|
|The Ask the Analyst Service...and more.|
Please remember to quote your order number and customer number.
You can also renew by calling: +44 (0)20 7017 5540.